These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32282296)

  • 41. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
    Müller II; Müller KA; Karathanos A; Schönleber H; Rath D; Vogel S; Chatterjee M; Schmid M; Haas M; Seizer P; Langer H; Schaeffeler E; Schwab M; Gawaz M; Geisler T
    Atherosclerosis; 2014 Dec; 237(2):426-32. PubMed ID: 25463068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes.
    Brueckmann M; Bertsch T; Lang S; Sueselbeck T; Wolpert C; Kaden JJ; Jaramillo C; Huhle G; Borggrefe M; Haase KK
    Clin Chem Lab Med; 2004; 42(10):1132-9. PubMed ID: 15552272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of inflammation-mediated response on pan-coronary plaque vulnerability, myocardial viability and ventricular remodeling in the postinfarction period - the VIABILITY study: Protocol for a non-randomized prospective clinical study.
    Morariu M; Hodas R; Benedek T; Benedek I; Opincariu D; Mester A; Chitu M; Kovacs I; Rezus C; Pasaroiu D; Mitra N; Szilágyi SM; Georgescu D; Rezus E
    Medicine (Baltimore); 2019 Apr; 98(17):e15194. PubMed ID: 31027064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction.
    Goswami B; Rajappa M; Mallika V; Shukla DK; Kumar S
    Clin Chim Acta; 2009 Oct; 408(1-2):14-8. PubMed ID: 19576194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous.
    Gualandro DM; Campos CA; Calderaro D; Yu PC; Marques AC; Pastana AF; Lemos PA; Caramelli B
    Atherosclerosis; 2012 May; 222(1):191-5. PubMed ID: 22410124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [MINOCA in Iceland. Acute coronary syndrome in patients with normal or nonobstructive coronary arteries].
    Vignisson ST; Gudmundsdottir IJ; Gudnason T; Danielsen R; Gardarsdottir M; Andersen K
    Laeknabladid; 2018 Mai; 104(5):237-242. PubMed ID: 29717990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes.
    Dimitroglou Y; Aggeli C; Theofilis P; Tsioufis P; Oikonomou E; Chasikidis C; Tsioufis K; Tousoulis D
    Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serial changes in plasma levels of cytokines in patients with coronary artery disease.
    Heinisch RH; Zanetti CR; Comin F; Fernandes JL; Ramires JA; Serrano CV
    Vasc Health Risk Manag; 2005; 1(3):245-50. PubMed ID: 17319110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor necrosis factor superfamily molecules in acute coronary syndromes.
    Aukrust P; Sandberg WJ; Otterdal K; Vinge LE; Gullestad L; Yndestad A; Halvorsen B; Ueland T
    Ann Med; 2011 Mar; 43(2):90-103. PubMed ID: 21039303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics.
    Lee JM; Choi G; Koo BK; Hwang D; Park J; Zhang J; Kim KJ; Tong Y; Kim HJ; Grady L; Doh JH; Nam CW; Shin ES; Cho YS; Choi SY; Chun EJ; Choi JH; Nørgaard BL; Christiansen EH; Niemen K; Otake H; Penicka M; de Bruyne B; Kubo T; Akasaka T; Narula J; Douglas PS; Taylor CA; Kim HS
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):1032-1043. PubMed ID: 29550316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar Hernández J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 2():S239-40. PubMed ID: 17017109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome.
    Versteylen MO; Kietselaer BL; Dagnelie PC; Joosen IA; Dedic A; Raaijmakers RH; Wildberger JE; Nieman K; Crijns HJ; Niessen WJ; Daemen MJ; Hofstra L
    J Am Coll Cardiol; 2013 Jun; 61(22):2296-305. PubMed ID: 23562925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redefining residual inflammatory risk after acute coronary syndrome.
    Del Buono MG; Montone RA; Iannaccone G; Rinaldi R; La Vecchia G; Camilli M; Gurgoglione FL; Russo M; Lombardi M; D'amario D; Niccoli G
    Future Cardiol; 2022 Feb; 18(2):115-123. PubMed ID: 34397269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy.
    Gin AL; Vergallo R; Minami Y; Ong DS; Hou J; Jia H; Soeda T; Hu S; Zhang S; Lee H; Yu B; Jang IK
    Coron Artery Dis; 2016 Dec; 27(8):629-635. PubMed ID: 27468140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation and its resolution as determinants of acute coronary syndromes.
    Libby P; Tabas I; Fredman G; Fisher EA
    Circ Res; 2014 Jun; 114(12):1867-79. PubMed ID: 24902971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes.
    Mizia-Stec K; Gasior Z; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Kobielusz-Gembala I
    Coron Artery Dis; 2003 Sep; 14(6):431-8. PubMed ID: 12966263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
    Maracle CX; Agca R; Helder B; Meeuwsen JAL; Niessen HWM; Biessen EAL; de Winther MPJ; de Jager SCA; Nurmohamed MT; Tas SW
    Atherosclerosis; 2018 Mar; 270():33-41. PubMed ID: 29407886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.